[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100343432":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":24,"studyPopulation":17,"armGroups":25,"interventions":38,"overallOfficials":17,"centralContacts":47,"locations":57,"responsibleParty":74,"collaborators":17,"id":76,"slug":17,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":17,"eligibilityCriteria":80,"healthyVolunteers":77,"sex":81,"minAge":82,"maxAge":17,"enrollmentInfo":83,"targetDuration":17,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":17,"overallStatus":59,"whyStopped":17,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Masaryk Memorial Cancer Institute","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"Management of acute toxicity of radiotherapy with acupuncture: Reducing the grade of acute toxicity in radiotherapy","Reducing the grade of acute toxicity in radiotherapy.","six months after the end of radiotherapy",[14],{"measure":15,"description":16,"timeFrame":12},"Management of chronic toxicity of radiotherapy with acupuncture: Lower incidence of chronic toxicity of radiotherapy","Lower incidence of chronic toxicity of radiotherapy.",null,{"allocation":19,"interventionModel":20,"interventionModelDescription":17,"primaryPurpose":21,"observationalModel":17,"timePerspective":17,"maskingInfo":22},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":23,"maskingDescription":17,"whoMasked":17},"NONE","The study will enroll 100 patients in current radiotherapy of the head and neck cancer with acute radiotoxic symptoms at least of G1. The patients will be randomized (by ticket) in two regimens 1:1.\n\nRegimen A (control regimen): standard support treatment of adverse events of the radiotherapy.\n\nRegimen B (acupuncture regimen): standard support treatment of adverse events of the radiotherapy and acupuncture.\n\nDue to the disease and patients differences, treatment will be individualized. Used acupuncture points will be documented. The patients difficulties will be observed and their medication and will be recorded in the patient diary.\n\nPossible skin toxicities wil be documented by the photography.\n\nBefore the randomization, all subjects will sign the voluntary informed consent. After the achievement of 50 enrolled subjects in any regimen, the enrollment will continue only to the other regimen.\n\nHead and neck cancer therapy will include only curative and adjuvant radiotherapy.",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"Regimen A","ACTIVE_COMPARATOR","Regimen A (control regimen): standard support treatment of adverse events of the radiotherapy.",[31],"Drug: Standard supportive therapy",{"label":33,"type":34,"description":35,"interventionNames":36},"Regimen B","EXPERIMENTAL","Regimen B (acupuncture regimen): standard support treatment of adverse events of the radiotherapy and acupuncture.",[37,31],"Other: Acupuncture",[39,43],{"type":6,"name":40,"description":41,"armGroupLabels":42,"otherNames":17},"Acupuncture","Schedule of the acupuncture:\n\nAcupuncture may be done ambulant or during hospitalisation . Acupuncture will be administered 1-3 times a week ( in case of severe toxicity and problems caused by the radiotherapy, it may continue also after the termination of the radiotherapy.) Acupuncture needles will be left for 5- 30 minutes, as per individual need of the patients.\n\nAcupuncture will be performed by a physician trained in acupuncture.",[33],{"type":44,"name":45,"description":45,"armGroupLabels":46,"otherNames":17},"DRUG","Standard supportive therapy",[27,33],[48,54],{"name":49,"role":50,"phone":51,"phoneExt":52,"email":53},"Renata Hejnová, Msc","CONTACT","+42054313","6232","renata.hejnova@mou.cz",{"name":55,"role":50,"phone":17,"phoneExt":17,"email":56},"Regina Demlová, MD,Ph.D.","demlova@mou.cz",[58],{"facility":5,"status":59,"city":60,"state":17,"zip":61,"country":62,"countryCode":17,"cosmosGeoPoint":63,"geoPoint":68,"contacts":69},"RECRUITING","Brno","65653","Czechia",{"type":64,"coordinates":65},"Point",[66,67],16.60796,49.19522,{"lat":67,"lon":66},[70],{"name":71,"role":50,"phone":51,"phoneExt":72,"email":73},"Radana Dymáčková, MD","1130","radana.dymackova@mou.cz",{"type":75,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100343432",false,"NCT03751566","Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors","Inclusion Criteria:\n\n* Curative and adjuvant radiotherapy for head and neck tumors;\n* PS 1-2;\n* Patient collaboration in evaluation of the toxicity diary.\n\nExclusion Criteria:\n\n* Palliative radiotherapy in the head and neck tumor;\n* PS 3;\n* Non-compliance of the patient.","ALL","18 Years",{"count":84,"type":85},60,"ESTIMATED","INTERVENTIONAL",[88],"NA","The aim of the study is to evaluate the benefit of the acupuncture as healing modalities in the therapy of acute toxicity of radiotherapy.",[91],"Malignant Tumor of Soft Tissue of Head, Face and Neck","2025-09-23",{"date":94,"type":95},"2025-09-25","ACTUAL",{"date":97,"type":95},"2021-10-05",{"date":99,"type":85},"2026-10-04",{"name":5,"class":6},1]